For the 5th time since the onset of the Covid-19 pandemic in early 2020, the skyrocketing stock price of Cambridge, Massachusetts-based vaccine maker Moderna has produced a billionaire
the team that first inserted mutations from another coronavirus, the one that causes MERS, into the SARS-CoV-2 virus' genetic sequence to create a piece of the spike protein which could teach the immune system to fight it.who made ten-figure fortunes with companies involved in the battle against Covid-19.
In an interview with his alma mater’s magazine for its Summer 2021 issue, he linked Moderna’s success to the biotech industry’s entrepreneurial start-up culture.UCSF Magazine. “In biotech, we often build upon research coming out of academia and try to translate it into something that impacts human health.”
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Moderna Asks FDA for Adolescent COVID Vaccine ApprovalModerna has filed for emergency use authorization from the FDA to give its vaccine to kids and teens aged 12-17, the company said in a news release.
Read more »
Novavax vaccine over 90% effective in protecting against COVID-19 infection, study showsNovavax expects to request federal authorization for its vaccine this summer after it completes final chemistry, manufacturing and control requirements.
Read more »
Large study finds that vaccine maker Novavax's shot is about 90% effectiveVaccine maker Novavax said its shot was highly effective against COVID-19 and also protected against variants in a large, late-stage study in the U.S. and Mexico.
Read more »
Novavax Covid vaccine shows over 90 percent efficacy, drugmaker saysCompany says study of nearly 30,000 volunteers in US and Mexico shows its vaccine protects against variants and will seek authorisation by the third quarter of 2021.
Read more »
Biden And Trudeau Discussed U.S.-Canada Border At G7, But No Decision YetWith Canada's vaccine rollout humming along, there is optimism that border restrictions could ease very soon.
Read more »
Novavax Says COVID Vaccine Works Against VariantsNovavax’s COVID-19 vaccine is highly effective -- 90.4% effective overall -- and protects against coronavirus variants, the company announced Monday.
Read more »